Shamil Cooray

Mr. Shamil Cooray

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2018 in Human Reproduction Update
Verified
Journal Article
Closed access
PDF file
NKN S Kakoly
N S Kakoly
MKM B Khomami
M B Khomami
AJA E Joham
A E Joham
SCShamil Cooray
Shamil Cooray
MMM L Misso
M L Misso
LMLisa Moran
Lisa Moran
Our prior meta-analyses demonstrated an increased prevalence of impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) with polycystic ovary syndrome (PCOS), but with substantial clinical heterogeneity. We aimed to update our previous review to quantify the prevalence of IGT and T2DM in PCOS with only quality studies (good and fair quality). We also aimed to examine the contribution of parameters including ethnicity, obesity and method of diagnosing T2DM in explaining the observed heterogeneity in IGT and T2DM prevalence in PCOS. We conducted a literature search (MEDLINE, CINAHL, EMBASE, clinical trial registries and hand-searching) up to June 2016 to identify studies reporting the prevalence of dysglycemia (IGT and T2DM) in women with and without PCOS. We included studies where women with PCOS (defined according to original National Institute of Health) were compared to women without PCOS for the end-points of the prevalence of IGT or T2DM. We excluded case reports, case series, editorials, and narrative reviews. Studies where PCOS was diagnosed by self-report, or where IGT or T2DM were measured by fasting glucose, only were excluded. We assessed the methodological quality of the included studies using a priori criteria based on the Newcastle–Ottawa Scaling (NOS) for non-randomized studies. Data are presented as odds ratio (OR) (95% CI) with random-effects meta-analysis by Mantel–Haenszel methods. We assessed the contribution of demographic and clinical factors to heterogeneity using subgroup and meta-regression analysis. We reviewed 4530 studies and included 40 eligible studies in the final analysis. On meta-analysis of quality studies, women with PCOS had an increased prevalence of IGT (OR = 3.26, 95% CI: 2.17–4.90) and T2DM (OR = 2.87, 95% CI: 1.44–5.72), which differed by ethnicity (for IGT, Asia: 5-fold, the Americas: 4-fold and Europe: 3-fold), was higher with obesity, and doubled among studies using self-report or administrative data for diagnosing diabetes. The ethnicity-related difference retained its significance for Asia and Europe in BMI-matched subgroups. Clear contributors to heterogeneity did not emerge in meta-regression. Our findings underscore the importance of PCOS as a cause of dysglycemia with a higher prevalence of IGT and T2DM. They support the relevance of ethnicity and obesity and emphasize the need for accurate diagnostic methods for diabetes. CRD42017056524.

19 October 2018 in Obesity Reviews
Verified
Journal Article
Closed access
PDF file
SLSiew Lim
Siew Lim
NKN. S. Kakoly
N. S. Kakoly
JTJ. W. J. Tan
J. W. J. Tan
GFG. Fitzgerald
G. Fitzgerald
MKMahnaz Bahri Khomami
Mahnaz Bahri Khomami
LML. J. Moran
L. J. Moran

20 March 2020 in Diabetologia
Verified
Journal Article
Open access
PDF file
TGthe INSPIRED research group
the INSPIRED research group
AEAoife Egan
Aoife Egan
DBDelia Bogdanet
Delia Bogdanet
TGTomás P. Griffin
Tomás P. Griffin
OKOratile Kgosidialwa
Oratile Kgosidialwa
FDFidelma Dunne
Fidelma Dunne
Aims/hypothesis: The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM). Methods: We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were brought forward for discussion at a face-to-face consensus meeting where the COS was finalised. Results: Our review identified 74 GDM prevention and 116 GDM treatment outcomes, which were presented to stakeholders in round 1 of the e-Delphi study. Round 1 was completed by 173 stakeholders, 70% (121/173) of whom went on to complete round 2; 84% (102/121) of round 2 responders completed round 3. Twenty-two GDM prevention outcomes and 30 GDM treatment outcomes were discussed at the consensus meeting. Owing to significant overlap between included prevention and treatment outcomes, consensus meeting stakeholders agreed to develop a single prevention/treatment COS. Fourteen outcomes were included in the final COS. These consisted of six maternal outcomes (GDM diagnosis, adherence to the intervention, hypertensive disorders of pregnancy, requirement and type of pharmacological therapy for hyperglycaemia, gestational weight gain and mode of birth) and eight neonatal outcomes (birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, neonatal hypoglycaemia, neonatal death and stillbirth). Conclusions/interpretation: This COS will enable future GDM prevention and treatment trials to measure similar outcomes that matter to stakeholders and facilitate comparison and combination of these studies. Trial registration: This study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/studies/details/686/

1 November 2011 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
SCShamil Cooray
Shamil Cooray
SESally M. MBChB Edmonds
Sally M. MBChB Edmonds
STStephen Mbbs Tong
Stephen Mbbs Tong
SSSumudu P. Mbbs Samarasekera
Sumudu P. Mbbs Samarasekera
CWClare L. MBChB Whitehead
Clare L. MBChB Whitehead
OBJECTIVE: To characterize the symptoms that immediately precede eclamptic seizures. METHODS: We did a prospective observational study of all women admitted to a single center in Tanzania between May 1, 2007 and April 30, 2008 who had an eclamptic seizure. During their admission they were asked a uniform set of questions related to symptoms preceding the seizure. RESULTS: There were 3,267 deliveries and 46 cases of eclampsia (1.4%). Neurologic symptoms (headache [80%] with or without visual disturbance [45%]) were the most common prodrome symptoms, regardless of degree of hypertension or whether the seizure occurred antepartum or postpartum. Twenty percent of women with eclampsia reported no neurologic symptoms before seizure. CONCLUSION: Neurologic symptoms commonly precede eclampsia. A minority of patients with eclampsia (17%) had no prodromal symptoms before their eclamptic seizure. Premonitory symptoms may provide an early warning of imminent eclampsia. LEVEL OF EVIDENCE: III

1 August 2020 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
STShakila Thangaratinam
Shakila Thangaratinam
SCShamil Cooray
Shamil Cooray
NSNithya Sukumar
Nithya Sukumar
MHMohammed S B Huda
Mohammed S B Huda
RDRoland Devlieger
Roland Devlieger
HTHelena J Teede
Helena J Teede
The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario, and usual guidelines and care pathways should be re-implemented as soon as possible and appropriate.

1 July 2010 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
JKJonathan K. Kam
Jonathan K. Kam
SCShamil Cooray
Shamil Cooray
JSJulian Smith
Julian Smith
AAAubrey A. Almeida
Aubrey A. Almeida